GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Other Operating Expense

Laurus Labs (BOM:540222) Other Operating Expense : ₹22,155 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Other Operating Expense?

Laurus Labs's Other Operating Expense for the three months ended in Mar. 2024 was ₹5,784 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹22,155 Mil.

Laurus Labs's quarterly Other Operating Expense increased from Sep. 2023 (₹5,489 Mil) to Dec. 2023 (₹5,665 Mil) and increased from Dec. 2023 (₹5,665 Mil) to Mar. 2024 (₹5,784 Mil).

Laurus Labs's annual Other Operating Expense increased from Mar. 2022 (₹12,743 Mil) to Mar. 2023 (₹17,926 Mil) and increased from Mar. 2023 (₹17,926 Mil) to Mar. 2024 (₹22,155 Mil).


Laurus Labs Other Operating Expense Historical Data

The historical data trend for Laurus Labs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Other Operating Expense Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,143.50 10,212.10 12,743.40 17,925.70 22,154.90

Laurus Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,877.90 5,217.00 5,488.70 5,665.00 5,784.20

Laurus Labs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹22,155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laurus Labs Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines